Search

Author/Creator Parry, Tom J.

1. An optimized dosing regimen of cimaglermin (neuregulin 1β3, glial growth factor 2) enhances molecular markers of neuroplasticity and functional recovery after permanent ischemic stroke in rats. Issue 3 (11th December 2015)

Authors:
Iaci, Jennifer F.; Parry, Tom J.; Huang, Zhihong; Pavlopoulos, Elias; Finklestein, Seth P.; Ren, Jingmei; Caggiano, Anthony
Journal:
Journal of neuroscience research
Issue:
Volume 94:Issue 3(2016)
Page Start:
253
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Anti‐Remodeling and Anti‐Fibrotic Effects of the Neuregulin‐1β Glial Growth Factor 2 in a Large Animal Model of Heart Failure. Issue 5 (23rd October 2014)

Authors:
Galindo, Cristi L.; Kasasbeh, Ehab; Murphy, Abigail; Ryzhov, Sergey; Lenihan, Sean; Ahmad, Farhaan A.; Williams, Philip; Nunnally, Amy; Adcock, Jamie; Song, Yanna; Harrell, Frank E.; Tran, Truc‐Linh; Parry, Tom J.; Iaci, Jen; Ganguly, Anindita; Feoktistov, Igor; Stephenson, Matthew K.; Caggiano, ...
Journal:
Journal of the American Heart Association
Issue:
Volume 3:Issue 5(2014:Oct.)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Pharmacological Characterization of a Novel Neuroactive Steroid Prodrug, NTS-104, and Its Neuroprotective Activity in Experimental Stroke Models. Issue 11 (28th September 2022)

Authors:
Zhang, Li; Schwartz-Byrne, Robin; Gertz, Steven; McGuire, Matthew; Woodhouse, Colleen; Powell, Brianna; Wei, Min; Li, Chao; Billing, Clare B.; Verdoorn, Todd A.; Lam, Leslie; Parry, Tom J.; Buller, Benjamin; Zhang, Zheng Gang; Poulsen, David; Chopp, Michael
Journal:
Stroke
Issue:
Volume 53:Issue 11(2022)
Page Start:
3455
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗